Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 9,156,635 $ 6,062,173
Prepaid research and development 588,931 9,931
Prepaid expenses and other current assets 194,054 389,501
Total Current Assets 9,939,620 6,461,605
Other Assets:    
Fixed Assets, net 54,287 58,149
Intangible assets, net 4,759 5,041
Acquired in-process research and development 455,000 455,000
Right-to-use Asset 220,660 246,209
Goodwill 248,971 248,971
Total Assets 10,923,297 7,474,975
Current Liabilities:    
Accounts payable 617,778 286,192
Accrued expenses 1,009,042 2,376,930
Accrued expenses, related party 175,000
Lease liability, current 53,136 49,585
Other current liabilities 11,860 9,683
Total Current Liabilities 1,866,816 2,722,390
Contingent liabilities 892,000 1,014,000
Lease liability, non-current 179,702 207,375
Deferred tax liability 23,399 23,399
Total Liabilities 2,961,917 3,967,164
Commitments and contingencies
Shareholders’ Equity    
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at June 30, 2022 and December 31, 2021
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 25,853,962 and 20,946,712 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 25,854 20,947
Additional paid in capital 65,634,012 54,429,979
Accumulated deficit (57,698,486) (50,943,115)
Total Shareholders’ Equity 7,961,380 3,507,811
Total Liabilities and Shareholders’ Equity $ 10,923,297 $ 7,474,975